AstraZeneca (AZN -0.3%) starts to hear a growing chorus of investors and analysts calling for a...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

AstraZeneca (AZN -0.3%) starts to hear a growing chorus of investors and analysts calling for a major shakeup of its board and management team amid a bit of a downward spiral. Bernstein Research's Jack Scannell thinks that instead of having marketing execs and attorneys running the show - the company should turn to either an Attila the Hun type of cost-slasher or a visionary scientist to right the ship.